In addition, we performed comparative genome hybridization (CGH) studies using the HCC oncogenomic database, indicating that increased chromosome 7q36.1, where EZH2 located, copy number gain/amplification was observed in HCC patients (Fig. 2b). This evidence concerns the gene EZH2 and hepatocellular carcinoma.